Appeal No. 1997-2830
Application 08/440,362
Claim 1 is illustrative of the claims on appeal and reads
as follows:
1. A method for reducing hyperglycemia and stabilizing
the level of serum glucose in humans comprising administering
between about 1,000 and 10,000 micrograms per day of chromium
as synthetic chromic tripicolinate to a human in need thereof.
The prior art reference relied upon by the examiner is:
Boynton et al. (Boynton) 5,087,623 Feb. 11, 1992
OPINION
In reaching our decision in this appeal, we have given careful consideration to the
appellant’s specification and claims, to the applied prior art reference, and to the
respective positions articulated by the appellant and the examiner.
Rather than reiterate the conflicting viewpoints advanced by the examiner and the
appellant regarding the above-noted rejection, we make reference to the examiner's
Answer (Paper No. 11, August 12, 1996) for the examiner's complete reasoning in support
2
Page: Previous 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007